Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Relationship between invasive hemodynamics and liver function in advanced heart failure
Julie K K Vishram-Nielsen1, Tania Deis1, Louise Balling1
1Centre for Cardiac, Vascular, Pulmonary and Infectious Diseases, Rigshospitalet, University Hospital of Copenhagen , Copenhagen , Denmark.
Insights
In advanced heart failure patients, central venous pressure (CVP) correlates with liver function markers. Improving CVP through decongestion may enhance liver function in these patients.
Area of Science:
- Cardiology
- Hepatology
- Internal Medicine
Background:
- Advanced heart failure (AHF) significantly impacts multiple organ systems, including the liver.
- Understanding the relationship between liver function (LF) and hemodynamics is crucial for managing AHF patients.
- Optimizing medical therapy is key in AHF, but its effect on liver function requires further investigation.
Purpose of the Study:
- To investigate the cross-sectional and longitudinal associations between liver function tests and invasive hemodynamic parameters in AHF patients.
- To determine if interventions aimed at improving hemodynamics, such as decongestion, can positively influence liver function in AHF.
Main Methods:
- Retrospective analysis of 309 AHF patients (left ventricular ejection fraction < 45%) undergoing right heart catheterization (RHC).
- Hemodynamic measurements included pulmonary capillary wedge pressure (PCWP), central venous pressure (CVP), cardiac index (CI), and mean arterial pressure (MAP).
- Liver function was assessed via plasma alanine transaminase (ALT), alkaline phosphatase (ALP), bilirubin, albumin, lactate dehydrogenase, and prothrombin time/International Normalized Ratio (PT/INR). RHC and LF were repeated in 33 patients.
Main Results:
- Central venous pressure (CVP) showed significant associations with alkaline phosphatase (ALP), bilirubin, and international normalized ratio (INR).
- Pulmonary capillary wedge pressure (PCWP) and cardiac index (CI) were associated with bilirubin levels.
- Longitudinal analysis revealed that changes in CVP positively correlated with changes in bilirubin, a marker of biliary excretion.
Conclusions:
- In optimally treated AHF patients, CVP is linked to both biliary excretion and liver synthesis markers.
- Changes in CVP over time are associated with alterations in markers of biliary excretion.
- Decongestion strategies may offer a therapeutic benefit by improving liver function in advanced heart failure.
Abstract:
Objective. To examine how liver function (LF) relates to invasive hemodynamics cross-sectionally and longitudinally, in advanced heart failure (AHF) patients treated with maximally tolerated medical HF therapy. Design. A retrospective study of 309 consecutive AHF patients with a left ventricular ejection fraction < 45% treated with maximally tolerated medical HF therapy who were referred for AHF therapies. All patients underwent right heart catheterization (RHC) using Swan-Ganz catheters. Cardiac output was measured using thermodilution. Measurements of pulmonary capillary wedge pressure (PCWP), central venous pressure (CVP), cardiac index (CI) and mean arterial pressure (MAP) were obtained. RHC and evaluation of LF were repeated (median (IQR) = 186.5 (150-208) days) in 33 patients. Results. Mean (SD) age was 50 (±13) years, and 239 (77%) were men. Only 22 (7%) were treated with inotropes, and none were receiving mechanical circulatory support. Median (IQR) plasma alanine transaminase (ALT) was 32 (22-53) U/l, alkaline phosphatase (ALP) 82 (63-122) U/l, bilirubin 14 (9-22) µmol/l, albumin 39 (35-43) g/l, lactate dehydrogenase 212 (175-275) U/l, and the prothrombin time/International Normalized Ratio (PT/INR) 1.1 (1.0-1.3). In multivariate analyses significant associations between LF tests and hemodynamics were seen for CVP: ALP (β = 0.031, p = .0002), bilirubin (β = 0.027, p = .004), and INR (β = 0.013, p = .002). PCWP (β = 0.020, p = .002) and CI (β = -0.17, p = .005) were also associated with bilirubin. Over time, changes in bilirubin correlated positively with changes in CVP (β = 1.496, p = .005). Conclusion. In optimally treated AHF patients, CVP was associated with both markers of biliary excretion and liver synthesis function, whereas changes in CVP were associated with changes in markers of biliary excretion. Decongestion may improve measures of LF in AHF.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management

